The costs of treating hypertension

Preview

Hypertension is a common target of cost-containment measures because so many people receive so much medication for it. However, to paraphrase Oscar Wilde's sentiments on being talked about: There is only one thing worse than the cost of treating hypertension, and that may be the cost of not treating hypertension. Dr Elliott describes some reasonable methods of cutting down on drug costs that do not result in insufficient or more costly medical care in the long term.

Additional information

Notes on contributors

William J. Elliott

William J. Elliott, MD, PhD Dr Elliott is associate professor of preventive medicine, Rush Medical College of Rush University, Chicago. He is a clinical pharmacologist with special research interests in risk assessment, pharmacoeconomics, and cost-benefit estimations.